New research on Covid vaccines published: Heart diseases...
According to a newly published study, Covid-19 vaccines reduce the risks of blood clotting and heart failure.
12punto
12PUNTO FOREIGN NEWS
Researchers examining the impact of Covid-19 on cardiovascular diseases analyzed the health data of more than 20 million people in the UK, Spain, and Estonia. The study found consistent evidence that the vaccines provide protection against serious cardiovascular complications of the disease.
Oxford-AstraZeneca, Pfizer, BioNTech and Moderna developed by the companies mRNA based Covid-19 vaccines have been proven to be highly effective in preventing severe illness during the pandemic.
One of the authors of the study, at the University of Oxford, professor of pharmacology and pharmacoepidemiology Daniel Prieto-Alhambra, "What we have shown in this very large study is that vaccinated individuals have a much lower risk of developing these post-Covid complications." said.
Prieto-Alhambra stated, "The main finding we have obtained is that if you get vaccinated, your risk of developing cardiovascular and thromboembolic complications after Covid will be significantly reduced. This is very reassuring, especially for people who are at high risk or who are afraid of cardiovascular complications or blood clots." he added.
The study examines whether Covid vaccines lead to heart and vascular problems as alleged by comparing the health data of people who contracted Covid-19 with those who were vaccinated.
According to the research, people who received mRNA vaccines faced 55 percent fewer heart failure and blood clotting issues compared to those who did not. In light of the findings, the researchers demonstrated that people who received the mRNA vaccine are 'safer' than those who did not.
However, according to the same study, it is also noted that mRNA vaccines increase the risk of heart disease and clotting in 'special cases.' The definition of 'special case' is used in the study to refer to 'exceptional situations,' such as individuals who have previously had certain illnesses or have a genetic predisposition.